000 01504 a2200421 4500
005 20250517215433.0
264 0 _c20181212
008 201812s 0 0 eng d
022 _a1619-7089
024 7 _a10.1007/s00259-018-4031-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWalker, Zuzana
245 0 0 _aClinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia.
_h[electronic resource]
260 _bEuropean journal of nuclear medicine and molecular imaging
_c07 2018
300 _a1534-1545 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aDementia
650 0 4 _aDiagnosis, Differential
650 0 4 _aFluorodeoxyglucose F18
650 0 4 _aHumans
650 0 4 _aParkinson Disease
_xdiagnostic imaging
650 0 4 _aParkinsonian Disorders
_xdiagnostic imaging
650 0 4 _aPositron-Emission Tomography
700 1 _aGandolfo, Federica
700 1 _aOrini, Stefania
700 1 _aGaribotto, Valentina
700 1 _aAgosta, Federica
700 1 _aArbizu, Javier
700 1 _aBouwman, Femke
700 1 _aDrzezga, Alexander
700 1 _aNestor, Peter
700 1 _aBoccardi, Marina
700 1 _aAltomare, Daniele
700 1 _aFestari, Cristina
700 1 _aNobili, Flavio
773 0 _tEuropean journal of nuclear medicine and molecular imaging
_gvol. 45
_gno. 9
_gp. 1534-1545
856 4 0 _uhttps://doi.org/10.1007/s00259-018-4031-2
_zAvailable from publisher's website
999 _c28408663
_d28408663